These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 26031592

  • 1. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.
    Niikura T, Yamamoto I, Nakada Y, Kamejima S, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():75-8. PubMed ID: 26031592
    [Abstract] [Full Text] [Related]

  • 2. A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.
    Fujimoto T, Nakada Y, Yamamoto I, Kobayashi A, Tanno Y, Yamada H, Miki J, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():81-5. PubMed ID: 26031594
    [Abstract] [Full Text] [Related]

  • 3. Acute T cell-mediated rejection accompanied by C4d-negative acute antibody-mediated rejection and cell debris in tubulus: A case report.
    Takamura T, Yamamoto I, Nakada Y, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():70-4. PubMed ID: 26031591
    [Abstract] [Full Text] [Related]

  • 4. Subclinical antibody-mediated rejection due to anti-human-leukocyte-antigen-DR53 antibody accompanied by plasma cell-rich acute rejection in a patient with cadaveric kidney transplantation.
    Katsuma A, Yamamoto I, Komatsuzaki Y, Niikura T, Kawabe M, Okabayashi Y, Yamakawa T, Katsumata H, Nakada Y, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():31-4. PubMed ID: 26971538
    [Abstract] [Full Text] [Related]

  • 5. Antibody-mediated rejection due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient.
    Sagasaki M, Nakada Y, Yamamoto I, Kawabe M, Yamakawa T, Katsumata H, Mafune A, Katsuma A, Kobayashi A, Koike K, Koike Y, Miki J, Yamada H, Kimura T, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():81-84. PubMed ID: 29968405
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
    Shimizu T, Tanabe T, Omoto K, Ishida H, Tanabe K.
    Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J, Xue W, Qing X, Jing X, Hou J, Tian X, Guo Q, He X, Cai J.
    Clin Transpl; 2014 Jan; ():223-30. PubMed ID: 26281149
    [Abstract] [Full Text] [Related]

  • 8. Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation.
    Furuya M, Yamamoto I, Kobayashi A, Nakada Y, Sugano N, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Yokoyama K, Yokoo T.
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():31-4. PubMed ID: 24842819
    [Abstract] [Full Text] [Related]

  • 9. A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology.
    Shimizu T, Tokiwa M, Yamaguchi Y.
    Clin Transplant; 2002 Jun; 16 Suppl 8():62-7. PubMed ID: 12464135
    [Abstract] [Full Text] [Related]

  • 10. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T, Ishida H, Toki D, Nozaki T, Omoto K, Tanabe K, Honda K, Koike J.
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [Abstract] [Full Text] [Related]

  • 11. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M, Mirocha J, Reinsmoen NL, Vo AA, Choi J, Kahwaji JM, Peng A, Villicana R, Jordan SC.
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [Abstract] [Full Text] [Related]

  • 12. The clinical and molecular significance of C4d staining patterns in renal allografts.
    Hayde N, Bao Y, Pullman J, Ye B, Calder BR, Chung M, Schwartz D, Alansari A, de Boccardo G, Ling M, Akalin E.
    Transplantation; 2013 Feb 27; 95(4):580-8. PubMed ID: 23274969
    [Abstract] [Full Text] [Related]

  • 13. Biopsy findings on a stable recipient after secondary donor specific antibody (DSA) positive and ABO incompatible kidney transplantation.
    Sugitani A, Takahashi C, Naka T, Hisamitsu K, Yamamoto O, Kobayashi N, Kimura M, Yoshida H, Hanaki T, Hamazoe R.
    Nephrology (Carlton); 2015 Jul 27; 20 Suppl 2():79-80. PubMed ID: 26031593
    [Abstract] [Full Text] [Related]

  • 14. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 15. Treatment of acute antibody-mediated rejection using bortezomib: a case report.
    Sin YH, Kim YJ, Oh JS, Lee JH, Kim SM, Kim JK.
    Nephrology (Carlton); 2015 Jul 27; 20 Suppl 2():86-9. PubMed ID: 26031595
    [Abstract] [Full Text] [Related]

  • 16. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
    Collins AB, Chicano SL, Cornell LD, Tolkoff-Rubin N, Goes NB, Saidman SL, Farrell ML, Cosimi AB, Colvin RB.
    Transplant Proc; 2006 Dec 27; 38(10):3427-9. PubMed ID: 17175293
    [Abstract] [Full Text] [Related]

  • 17. A suspected case of plasma cell-rich acute renal transplant rejection associated with de novo donor-specific antibody.
    Yoshikawa M, Kitamura K, Ishimura T, Hara S, Fujisawa M, Nishi S.
    Nephrology (Carlton); 2015 Jul 27; 20 Suppl 2():66-9. PubMed ID: 26031590
    [Abstract] [Full Text] [Related]

  • 18. Acute transplant glomerulopathy is associated with antibody-mediated rejection and poor graft outcome.
    Nair R, Fraer M, Agrawal N, Suneja M.
    Transplant Proc; 2010 Nov 27; 42(9):3507-12. PubMed ID: 21094805
    [Abstract] [Full Text] [Related]

  • 19. The impact of C4d staining as a humoral injury marker.
    Kara M, Demir F, Ata P, Ozel L, Gumrukcu G, Unal E, Canbakan M, Gucun M, Esadoglu V, Ozdemir E, Cemel H, Titiz MI.
    Transplant Proc; 2012 Nov 27; 44(6):1694-6. PubMed ID: 22841245
    [Abstract] [Full Text] [Related]

  • 20. Antibody-mediated rejection and treatment in pediatric patients: one center's experience.
    Gulleroglu K, Baskin E, Bayrakci US, Turan M, Ozdemir BH, Moray G, Karakayali H, Haberal M.
    Exp Clin Transplant; 2013 Oct 27; 11(5):404-7. PubMed ID: 24128133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.